Exam Details
Subject | dosage form design- ii | |
Paper | ||
Exam / Course | b.pharm | |
Department | ||
Organization | Gujarat Technological University | |
Position | ||
Exam Date | November, 2018 | |
City, State | gujarat, ahmedabad |
Question Paper
Seat No.: Enrolment
GUJARAT TECHNOLOGICAL UNIVERSITY
B.PHARM SEMESTER EXAMINATION -WINTER 2018
Subject Code: 280001 Date: 15/11/2018
Subject Name: Dosage Form Design- II
Time: 02:30 PM TO 05:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make Suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss in brief the Hixon and Crowell's cube root dissolution equation for controlled release dosage forms.
06
Explain biological and physicochemical factors, which are responsible for designing oral sustained release drug delivery system.
05
Explain loading dose and maintenance dose used in controlled release formulation.
05
Q.2
Explain lag time, burst effect and reservoir systems with respect to control release formulations.
06
Explain apparent volume of distribution. State its significance.
05
Describe preparation and evaluation of parenteral suspension.
05
Q.3
What is non-linear pharmacokinetic? Describe the equation that governs the non-linear Pharmacokinetics.
06
Write a note on osmotic ocular inserts. Mention the components of each part.
05
Give an account of approaches for designing of gastro retentive dosage forms.
05
Q.4
Discuss one compartment open model i.v. infusion model and discuss the effect of loading i.v. injection dose. Describe the derivation of various pharmacokinetic parameters for the model.
06
Classify liposomes? Why are considered versatile carriers for parenteral drug delivery.
05
Explain the significance of renal clearance and dosage regimen.
05
Q.5
What properties are required for the drug to be a candidate for transdermal drug deliverysystem? Explain formulation of transdermal drug delivery system.
06
Define clinical pharmacokinetics and explain dosage adjustment in patients with renal failure.
05
Write a note on Hydrogel.
05
Q.6
Define 'Drug interaction'. Discuss the factors that contribute to drug interaction. Give suitable examples.
06
Write a note on: Wagner-Nelson method used to estimate absorption rate constant
05
Define clearance, total body clearance and organ clearance. What is extraction ratio?
05
Q.7
Explain pharmacokinetic and pharmacodynamics parameters, which are considered in design of, modified drug delivery systems?
06
Enlist different approaches for formulation of colon targeted drug delivery system and explain any one of them.
05
Write a note on evaluation parameters of microsphere.
05
GUJARAT TECHNOLOGICAL UNIVERSITY
B.PHARM SEMESTER EXAMINATION -WINTER 2018
Subject Code: 280001 Date: 15/11/2018
Subject Name: Dosage Form Design- II
Time: 02:30 PM TO 05:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make Suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Discuss in brief the Hixon and Crowell's cube root dissolution equation for controlled release dosage forms.
06
Explain biological and physicochemical factors, which are responsible for designing oral sustained release drug delivery system.
05
Explain loading dose and maintenance dose used in controlled release formulation.
05
Q.2
Explain lag time, burst effect and reservoir systems with respect to control release formulations.
06
Explain apparent volume of distribution. State its significance.
05
Describe preparation and evaluation of parenteral suspension.
05
Q.3
What is non-linear pharmacokinetic? Describe the equation that governs the non-linear Pharmacokinetics.
06
Write a note on osmotic ocular inserts. Mention the components of each part.
05
Give an account of approaches for designing of gastro retentive dosage forms.
05
Q.4
Discuss one compartment open model i.v. infusion model and discuss the effect of loading i.v. injection dose. Describe the derivation of various pharmacokinetic parameters for the model.
06
Classify liposomes? Why are considered versatile carriers for parenteral drug delivery.
05
Explain the significance of renal clearance and dosage regimen.
05
Q.5
What properties are required for the drug to be a candidate for transdermal drug deliverysystem? Explain formulation of transdermal drug delivery system.
06
Define clinical pharmacokinetics and explain dosage adjustment in patients with renal failure.
05
Write a note on Hydrogel.
05
Q.6
Define 'Drug interaction'. Discuss the factors that contribute to drug interaction. Give suitable examples.
06
Write a note on: Wagner-Nelson method used to estimate absorption rate constant
05
Define clearance, total body clearance and organ clearance. What is extraction ratio?
05
Q.7
Explain pharmacokinetic and pharmacodynamics parameters, which are considered in design of, modified drug delivery systems?
06
Enlist different approaches for formulation of colon targeted drug delivery system and explain any one of them.
05
Write a note on evaluation parameters of microsphere.
05
Other Question Papers
Subjects
- agronomy and forestry of medicinal plants
- anatomy physiology & health education -ii
- anatomy, physiology and health education (aphe)
- applied mathematics (biostatistics)
- basic computer applications
- basic concepts of pharmacology and clinical pharmacy practice
- basics of computer applications
- bioavailability & therapeutic drug monitoring
- bioavailability and therapeutic drug monitoring
- biochemistry
- clinical pharmacy ii
- clinical pharmacy-i
- commerce of herbs and phytoconstitutents
- computer applications in drug discovery
- current advances in novel drug delivery systems
- cyber security
- disaster management
- dispensing pharmacy i
- dispensing pharmacy i and drug store management
- dispensing pharmacy ii and pharma industrial management
- dosage form design –i
- dosage form design- i
- dosage form design- ii
- dosage form design-i
- dosage form design-ii
- drug approval process
- environmental studies
- environmental toxicology and green audit
- food analysis
- forensic pharmacy
- forensic pharmacy-i
- genetic engineering and gene therapy
- green chemistry
- health education and community health
- herbal cosmetics
- hospital and community pharmacy
- hospital management and medical tourism
- hospital pharmacy, community pharmacy & forensic pharmacy
- hospital pharmacy, community pharmacy and dispensing pharmacy-ii
- human anatomy physiology
- human anatomy physiology and health education-ii
- human anatomy physiology-ii
- human anatomy, physiology and health education - i
- innovations in conventional drug delivery system
- instrumental and process validation
- intellectual property rights and patents
- medical writing and coding
- medicinal biochemistry
- nutraceuticals
- pathophysiology
- pharmaceutical analysis ii
- pharmaceutical analysis iii
- pharmaceutical analysis iv
- pharmaceutical analysis-i
- pharmaceutical analysis-ii
- pharmaceutical analysis-iv
- pharmaceutical chemistry – ii
- pharmaceutical chemistry – vi (organic chemistry – ii)
- pharmaceutical chemistry –viii (medicinal chemistry - ii)
- pharmaceutical chemistry iii
- pharmaceutical chemistry iv
- pharmaceutical chemistry vii
- pharmaceutical chemistry-i
- pharmaceutical chemistry-i (inorganic chemistry)
- pharmaceutical chemistry-ii (physical chemistry)
- pharmaceutical chemistry-iii (biochemistry – i)
- pharmaceutical chemistry-iv (organic chemistry-i)
- pharmaceutical chemistry-ix (medicinal chemistry-iii)
- pharmaceutical chemistry-v
- pharmaceutical chemistry-v (biochemistry-ii)
- pharmaceutical chemistry-vi (medicinal)
- pharmaceutical chemistry-vii
- pharmaceutical chemistry-viii
- pharmaceutical chemistry-x
- pharmaceutical chemistry-x (medicinal chemistry-iii)
- pharmaceutical engineering
- pharmaceutical engineering-ii
- pharmaceutical inorganic chemistry
- pharmaceutical marketing management
- pharmaceutical microbiology - i
- pharmaceutical microbiology & biotechnology i
- pharmaceutical microbiology &biotechnology- ii
- pharmaceutical microbiology and biotechnology - ii
- pharmaceutical organic chemistry
- pharmaceutical technology - i
- pharmaceutical technology – i
- pharmaceutical technology- ii
- pharmaceutical technology-i
- pharmaceutical technology-ii
- pharmaceutics-i
- pharmaceutics-ii
- pharmaceutivcal chemistry ix
- pharmacognosy iii
- pharmacognosy iv
- pharmacognosy vi
- pharmacognosy vii
- pharmacognosy vii (herbal formulations & complimentary therapies)
- pharmacognosy-i
- pharmacognosy-ii
- pharmacognosy-iii
- pharmacognosy-iv
- pharmacognosy-v
- pharmacognosy-v (plant bio technology)
- pharmacognosy-vi
- pharmacology -iii
- pharmacology & pharmacotherapeutics-ii
- pharmacology and pharmacotherapeutics - i
- pharmacology and pharmacotherapeutics - iii
- pharmacology and pharmacotherapeutics-iv
- pharmacology-i
- pharmacology-ii
- pharmacovigilance
- pharmacy practice
- physical pharmaceutics-ii
- physical pharmacy
- quality by design (qbd) and process analytical technology (pat)
- regulatory aspects of food and neutraceuticals
- remedial mathematics
- unit operation - i
- unit operation - ii